ETPrime

Biocon Share Price

  • 364.150.45 (0.13%)
  • Volume: 13,48,143
  • Closed
  • Last Updated On: 08 Sep, 2025, 03:45 PM IST
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Biocon Share Price
  • 364.150.45 (0.13%)
  • Volume: 13,48,143
Advertisment
Stock Recommendations

  • Potential
    Upside

  • 1 Year
    Target

BUY

Mean Recos by
16 Analysts

1

2

3

4

6

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside
Stock Reports Plus

/10

Stock Score

View Report
Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum
No Rating (NR)
Negative
Neutral
Positive
Unlock Stock Score

Biocon share price insights

  • Company has spent 5.88% of its operating revenues towards interest expenses and 20.6% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • Biocon Ltd. share price moved up by 0.13% from its previous close of Rs 363.70. Biocon Ltd. stock last traded price is 364.15

    Share PriceValue
    Today/Current/Last364.15
    Previous Day363.70363.80

InsightsBiocon

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		126.46
    EPS - TTM
    (₹)    		2.88
    MCap
    (₹ Cr.)    		48,685.53
    Sectoral MCap Rank
    		13
    PB Ratio
    (x)    		1.75
    Div Yield
    (%)    		0.14
    Face Value
    (₹)    		5.00
    Beta

    Beta

    1 Month0.87
    3 Months1.37
    6 Months0.95
    1 Year0.98
    3 Years1.08

    		0.87
    VWAP
    (₹)    		365.78
    52W H/L
    (₹)
    406.00 / 291.00

    Biocon Share Price Returns

    1 Day0.13%
    1 Week3.29%
    1 Month6.06%
    3 Months10.33%
    1 Year-2.56%
    3 Years21.3%
    5 Years-12.42%

    ET Stock ScreenersTop Score Companies

    Check whether Biocon belongs to analysts' top-rated companies list?

    View Stock Screeners

    Biocon News & Analysis

    View all Biocon Share News & Announcements

    Biocon Share Recommendations

    Recent Recos

    BUY

    Current

    Mean Recos by 16 Analysts

    Strong
    Sell    SellHoldBuyStrong
    Buy
    • Target₹270
    • OrganizationICICI Securities
    • SELL
    • Target₹351
    • OrganizationAxis Securities
    • BUY

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy6666
    Buy4444
    Hold3333
    Sell2222
    Strong Sell1111
    # Analysts16161616
    View all Stock Recommendations

    Biocon Financials

    • Insights

      • Employee & Interest Expense

        Company has spent 5.88% of its operating revenues towards interest expenses and 20.6% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income4,021.604,453.903,856.203,622.904,567.40
      Total Income Growth (%)-9.7115.506.44-20.6815.17
      Total Expenses3,648.003,754.703,476.903,298.903,185.90
      Total Expenses Growth (%)-2.847.995.403.55-6.76
      EBIT373.60699.20379.30324.001,381.50
      EBIT Growth (%)-46.5784.3417.07-76.55151.78
      Profit after Tax (PAT)31.40344.5025.10-16.00659.70
      PAT Growth (%)-90.891,272.51--102.43386.86
      EBIT Margin (%)9.2915.709.848.9430.25
      Net Profit Margin (%)0.787.730.65-0.4414.44
      Basic EPS (₹)0.262.880.21-0.135.51
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income598.40706.50627.00598.90552.50
      Total Income Growth (%)-15.3012.684.698.40-3.32
      Total Expenses549.80614.80-42.20518.30496.20
      Total Expenses Growth (%)-10.57-1,556.87-108.144.45-2.74
      EBIT48.6091.70669.2080.6056.30
      EBIT Growth (%)-47.00-86.30730.2743.16-8.16
      Profit after Tax (PAT)-8.3021.20584.003.200.90
      PAT Growth (%)-139.15-96.370.00255.56-93.57
      EBIT Margin (%)8.1212.98106.7313.4610.19
      Net Profit Margin (%)-1.393.0093.140.530.16
      Basic EPS (₹)-0.070.184.880.030.01
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue16,469.9015,621.2011,550.108,396.707,360.30
      Total Revenue Growth (%)5.4335.2537.5614.0813.90
      Total Expenses14,679.8014,000.2010,194.607,095.606,226.00
      Total Expenses Growth (%)4.8537.3343.6713.9717.15
      Profit after Tax (PAT)1,013.301,022.50462.70648.40740.50
      PAT Growth (%)-0.90120.99-28.64-12.44-1.03
      Operating Profit Margin (%)17.6017.5815.8816.7216.77
      Net Profit Margin (%)6.636.924.147.9210.42
      Basic EPS (₹)8.468.553.885.446.24
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue2,484.902,320.302,264.301,925.402,178.60
      Total Revenue Growth (%)7.092.4717.60-11.62-0.53
      Total Expenses2,431.502,184.502,155.901,785.701,819.80
      Total Expenses Growth (%)11.311.3320.73-1.871.01
      Profit after Tax (PAT)609.30119.302,848.4086.10280.50
      PAT Growth (%)410.73-95.813,208.25-69.30-36.38
      Operating Profit Margin (%)12.9415.728.938.0617.70
      Net Profit Margin (%)27.165.60142.924.9513.82
      Basic EPS (₹)5.091.0023.870.722.36

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets58,797.3056,070.7052,042.8020,394.0018,522.30
      Total Assets Growth (%)4.867.74155.1910.1128.24
      Total Liabilities31,084.8030,795.9029,554.0010,924.0010,014.70
      Total Liabilities Growth (%)0.944.20170.549.0841.84
      Total Equity27,712.5025,274.8022,488.809,470.008,411.70
      Total Equity Growth (%)9.6412.39137.4712.5813.93
      Current Ratio (x)1.140.991.452.191.81
      Total Debt to Equity (x)0.820.800.990.580.47
      Contingent Liabilities2,086.502,594.401,990.901,585.001,588.60
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets15,621.1013,768.2013,029.908,869.008,573.70
      Total Assets Growth (%)13.465.6746.923.443.16
      Total Liabilities4,096.702,855.902,113.90776.10666.60
      Total Liabilities Growth (%)43.4535.10172.3716.43-13.82
      Total Equity11,524.4010,912.3010,916.008,092.907,907.10
      Total Equity Growth (%)5.61-0.0334.882.354.91
      Current Ratio (x)1.253.993.684.073.94
      Total Debt to Equity (x)0.250.190.120.010.00
      Contingent Liabilities1,081.401,125.30754.80638.301,749.60

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 234.1 cr for investing activities which is an YoY decrease of 76.69%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities4,061.202,953.901,852.501,176.601,159.70
      Net Cash used in Investing Activities-234.10-1,004.50-14,281.80-1,699.10-3,624.70
      Net Cash flow from Financing Activities-1,854.00-2,332.7013,048.70242.102,564.00
      Net Cash Flow2,004.30-380.40641.10-243.30106.10
      Closing Cash & Cash Equivalent2,923.80919.501,294.80653.70897.00
      Closing Cash & Cash Equivalent Growth (%)217.98-28.9998.07-27.128.77
      Total Debt/ CFO (x)4.375.339.594.173.07
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities623.90-123.20219.3047.60478.40
      Net Cash used in Investing Activities-991.80-296.40-1,177.80-305.60-618.30
      Net Cash flow from Financing Activities494.80343.601,039.40112.0027.80
      Net Cash Flow127.20-74.3085.60-142.50-121.50
      Closing Cash & Cash Equivalent249.50122.30196.60111.00253.50
      Closing Cash & Cash Equivalent Growth (%)104.01-37.7977.12-56.21-32.40
      Total Debt/ CFO (x)4.60-16.565.921.590.00

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)4.685.162.587.699.83
      Return on Capital Employed (%)6.046.374.078.268.32
      Return on Assets (%)1.721.820.883.173.99
      Interest Coverage Ratio (x)4.874.276.8932.2920.66
      Asset Turnover Ratio (x)0.270.270.310.1338.36
      Price to Earnings (x)40.4931.0653.7662.1166.67
      Price to Book (x)1.891.601.394.766.51
      EV/EBITDA (x)13.8712.1715.5020.3226.99
      EBITDA Margin (%)28.6628.2225.8426.6726.83
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)5.281.0926.091.063.54
      Return on Capital Employed (%)2.092.551.441.694.47
      Return on Assets (%)3.900.8621.860.973.27
      Interest Coverage Ratio (x)1.762.294.24620.75898.00
      Asset Turnover Ratio (x)0.150.160.180.2023.65
      Price to Earnings (x)67.57270.278.70476.19175.44
      Price to Book (x)3.552.912.274.966.20
      EV/EBITDA (x)104.2572.7785.97159.29104.72
      EBITDA Margin (%)18.6421.4214.7914.2822.81

    Financial InsightsBiocon

    • Income (P&L)
    • Cash Flow

      • Employee & Interest Expense

        Company has spent 5.88% of its operating revenues towards interest expenses and 20.6% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 234.1 cr for investing activities which is an YoY decrease of 76.69%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Biocon Share Price Forecast

    • Get multiple analysts’ prediction on Biocon

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Biocon

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Biocon

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Biocon Technicals

    • Bullish / Bearish signals for Biocon basis selected technical indicators and moving average crossovers.

      5 Day EMA Crossover

      Bullish signal on daily chart

      Appeared on: 5 Sep 2025

      5D EMA: 359.13

      Last 4 Buy Signals:2 Sep 2025
      Date7 days Gain/Loss %
      2 Sep 20252.37%
      25 Aug 20250.93%
      13 Aug 20252.15%
      29 Jul 20251.22%

      Average price gain of 3.08% within 7 days of Bullish signal in last 5 years

      10 Day EMA Crossover

      Bullish signal on daily chart

      Appeared on: 5 Sep 2025

      10D EMA: 358.39

      Last 4 Buy Signals:3 Sep 2025
      Date7 days Gain/Loss %
      3 Sep 20250.83%
      18 Aug 20250.60%
      29 Jul 20251.22%
      19 Jun 20252.41%

      Average price gain of 2.94% within 7 days of Bullish signal in last 5 years

      Show More
    • 43%
      Positive Movement since
      1st Jan 2005 on basis
      56%
      Negative Movement since
      1st Jan 2005 on basis
      Exclude

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic367.17370.18375.53364.83361.82359.48354.13

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR8.329.219.69

    Biocon Peer Comparison

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Biocon126.461.764.686.041.7224.9017.609.368.461.140.824.37
          Alkem Labs27.915.1318.0619.2912.247.5420.4317.09181.112.760.090.56
          Aurobindo Pharma17.811.8510.6715.827.0010.6917.5111.0859.811.850.242.02
          Glenmark Pharma76.836.5411.8319.626.522.4914.857.8637.111.560.25-2.65
          Laurus Labs94.9710.508.0111.823.834.2512.336.386.651.220.604.48
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Suven Pharma
          • Ipca Labs
          • Ajanta Pharma
          • Gland Pharma
          • J B Chemicals

          Choose from Stocks

            See All Parameters

          Peers InsightsBiocon

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Biocon Shareholding Pattern

            • Loading...
              Showing Biocon Shareholding as on Jun 2025
              CategoryJun 2025Mar 2025Dec 2024Sep 2024
              Promoters54.4560.6460.6460.64
              Pledge0.000.000.000.00
              FII6.045.675.665.93
              DII22.8315.7215.3614.42
              Mutual Funds15.248.778.587.97
              Others16.6817.9718.3419.01
            • Showing Shareholding as on Jun 2025
              CategoryNo. of SharesPercentage% Change QoQ
              Promoters72,80,24,17654.45 %-6.18
              Pledge00.00 %0.00
              FII8,07,26,5156.04 %0.36
              DII30,51,48,70822.83 %7.10
              MF20,37,17,66815.24 %6.47
              Others22,30,64,23616.68 %-1.28

            Biocon MF Ownership

            • Equity: Value Oriented
              5

              • 1,122.83

                Amount Invested (in Cr.)

              • 2.39168968%

                % of AUM

              • 0.00

                % Change (MoM basis)

            • Equity: Mid Cap
              4

              • 546.77

                Amount Invested (in Cr.)

              • 2.42509411%

                % of AUM

              • 0.00

                % Change (MoM basis)

            • Equity: Large & MidCap
              3

              • 508.82

                Amount Invested (in Cr.)

              • 1.81%

                % of AUM

              • 0.00

                % Change (MoM basis)

            MF Ownership as on 31 July 2025

            View all Mutual Fund Schemes
            Top Searches:
            Biocon News Biocon Quarterly Results Biocon Dividend Biocon Q1 ResultsBiocon Q2 ResultsBiocon Q3 ResultsBiocon Q4 Results

            Biocon F&O Quote

              • Expiry

              Price

              365.350.50 (0.14%)

              Open Interest

              3,89,25,000-97,500 (-0.25%)

              OpenHighLowPrev CloseContracts TradedTurnover (₹ Lakhs)
              365.90368.85363.85364.851,15410,583.13

              Open Interest as of 08 Sep 2025

              • Type
              • Expiry
              • Strike Price

              Price

              6.85-0.30 (-4.20%)

              Open Interest

              11,25,0001,00,000 (9.76%)

              OpenHighLowPrev CloseContracts TradedTurnover (₹ Lakhs)
              7.508.556.407.151,0299,695.14

              Open Interest as of 08 Sep 2025

            Biocon Corporate Actions

            • Meeting DateAnnounced onPurposeDetails
              Aug 08, 2025May 08, 2025AGM-
              Aug 07, 2025Jul 08, 2025Board MeetingQuarterly Results
              Jun 06, 2025May 05, 2025POM-
              May 08, 2025Apr 02, 2025Board MeetingAudited Results & Final Dividend
              Apr 23, 2025Apr 21, 2025Board MeetingOthers
            • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
              Final10%0.5Jul 04, 2025May 08, 2025
              Final10%0.5Jul 05, 2024May 16, 2024
              Final30%1.5Jul 07, 2023May 24, 2023
              Final10%0.5Jun 30, 2022Apr 28, 2022
              Final10%0.5Jul 18, 2019Apr 25, 2019
            • All TypesEx-DateRecord DateAnnounced onDetails
              BonusJun 12, 2019Jun 13, 2019Apr 25, 2019Bonus Ratio: 1 share(s) for every 1 shares held
              BonusJun 15, 2017Jun 17, 2017Apr 27, 2017Bonus Ratio: 2 share(s) for every 1 shares held
              BonusSep 11, 2008Sep 12, 2008Apr 22, 2008Bonus Ratio: 1 share(s) for every 1 shares held

            About Biocon

            Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 48,685.53 Crore) operating in Pharmaceuticals sector. Biocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals, Other Operating Revenue, Waste and Sale of services for the year ending 31-Mar-2025. Show More

            • Executives

            • Auditors

            • KM

              Kiran Mazumdar Shaw

              Executive Chairperson
              SM

              Siddharth Mittal

              Managing Director & CEO
              EV

              Eric Vivek Mazumdar

              Non Exe.Non Ind.Director
              RR

              Ravi Rasendra Mazumdar

              Non Exe.Non Ind.Director
              Show More
            • B S R & Co. LLP

            Industry

            Pharma - Indian

            Key Indices Listed on

            Nifty Midcap 100, Nifty 200, Nifty 500, + 23 more

            Address

            20th K.M. Hosur Road,Electronics City,Bengaluru, Karnataka - 560100

            Contact

            investor.relations@biocon.com

            http://www.biocon.com

            More Details

            FAQs about Biocon share

            • 1. What's the Biocon share price today?
              Biocon share price is Rs 364.15 as on 08 Sep, 2025, 03:59 PM IST. Biocon share price is up by 0.13% based on previous share price of Rs. 356.85.
            • 2. What has been highest price of Biocon share in last 52 weeks?
              In last 52 weeks Biocon share had a high price of Rs 406.00 and low price of Rs 291.00
            • 3. What are the returns for Biocon share?
              Return Performance of Biocon Shares:
              • 1 Week: Biocon share price moved up by 3.29%
              • 3 Month: Biocon share price moved up by 10.33%
              • 6 Month: Biocon share price moved up by 9.13%
            • 4. What is the PE & PB ratio of Biocon?
              The PE ratio of Biocon stands at 126.3, while the PB ratio is 1.58.
            • 5. What is the market cap of Biocon?
              Biocon share has a market capitalization of Rs 48,685.53 Cr. Within Pharmaceuticals sector, it's market cap rank is 13.

            Trending in Markets

            Top Gainers As on 03:59 PM | 08 Sep 2025

            Suven Pharma 1,012.95
            90.06 (9.76%)
            Guj Mineral Dev.539.15
            30.15 (5.93%)
            Bharat Forge1,202.80
            66.10 (5.82%)
            Ashok Leyland137.29
            6.52 (4.99%)
            JP Power20.02
            0.95 (4.99%)

            Top Losers As on 03:57 PM | 08 Sep 2025

            Amber Enterprises7,473.00
            -320.50 (-4.12%)
            EID Parry1,067.30
            -45.50 (-4.09%)
            Trent5,315.50
            -213.00 (-3.86%)
            Godfrey Philips10,657.00
            -416.00 (-3.76%)
            Coromandel Int.2,185.20
            -72.71 (-3.22%)

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Biocon Share Price
            The Economic Times
            BrowseCompanies: